Press releases
- Chemed Reports First-Quarter 2024 Results
- VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
- Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
- VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
- Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
- Chemed Reports Fourth-Quarter 2023 Results
- Chemed Corporation Declares Quarterly Dividend of 40 Cents
- Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28
More ▼
Key statistics
On Tuesday, Chemed Corp (CXM:DUS) closed at 530.00, 2.91% above its post-IPO low of 515.00, set on Apr 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 525.00 |
---|---|
High | 530.00 |
Low | 520.00 |
Bid | 525.00 |
Offer | 540.00 |
Previous close | 525.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 15.14m |
Free float | 14.78m |
P/E (TTM) | 30.50 |
Market cap | 8.58bn USD |
EPS (TTM) | 18.58 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 18:31 BST.
More ▼